BRIDGEBIO PHARMA INC. - COMMON STOCK
23.42
22-十一月-24 16:44:58
15 分钟延时
股票
+0.18
+0.77%
今日范围
22.47 - 23.65
ISIN
N/A
来源
NASDAQ
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07 4月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
23 3月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
21 3月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
08 3月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
06 3月 2023 16:05:38 条件 Nasdaq GlobeNewswire
-
BridgeBio to Host Investor Call to Discuss Phase 2 Cohort 5 Data for Achondroplasia on March 6, 2023
03 3月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Business Update
23 2月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
17 2月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
13 2月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in February and March Investor Events
08 2月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma to Present at the J.P. Morgan Healthcare Conference
04 1月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
22 12月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in November Investor Events
09 11月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma, Inc. Reports Third Quarter 2022 Financial Results and Business Update
03 11月 2022 07:30:01 条件 Nasdaq GlobeNewswire
-
14 10月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
13 10月 2022 16:00:00 条件 Nasdaq GlobeNewswire